An alternative approach to a frequently used nerve block in patients with a broken hip in the emergency department

Opioid consumption in a supra-inguinal fascia iliaca compartment block compared to systemic analgesia in Emergency Department hip fracture patients, a cohort study

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

ISRCTN

Registry ID

ISRCTN74920258

Enrollment

Registered

2016-07-26

Start date

2014-05-01

Completion date

Unknown

Last updated

2019-03-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hip fracture Musculoskeletal Diseases Hip fracture

Interventions

Each patient will receive care as usual, which is pain treatment using a (supra-inguinal) FICB. NRS pain scores will be followed-up strictly and asked for at baseline, as well as 30, 60 and 120 in min

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Adult (18 years or older) patients 2. Radiologically confirmed hip fracture Removed 03/04/2017: 3. Will be treated with a supra-inguinal FICB in the ED

Exclusion criteria

Exclusion criteria: 1. Allergies for local anesthetics 2. Polytrauma patients 3. Not receiving a supra-inguinal FICB

Design outcomes

Primary

Measure	Time frame
Number of participants with a three-point decrease in Numerical Rating Scale (NRS) pain scores is measured prospectively for the FICB group at 30, 60 and 120 minutes after performing the nerve block and retrospectively from patient charts for those in the control group.	—

Secondary

Measure	Time frame
1. Decrease in Numerical Rating Scale (NRS) pain scores for different fracture types is measured at 30, 60 and 120 minutes after administration of the FICB for the FICB group and retrospectively from patient charts for those in the control group 2. Need for additional opioid analgesics is measured by emergency department and anesthesiology staff members, as well as members of the research team at 30, 60 and 120 minutes for the FICB group and retrospectively from patient charts for those in the control group 3. . Occurrence of side effects is measured by emergency department and anesthesiology staff members, as well as members of the research team at 30, 60 and 120 minutes for the FICB group and retrospectively from patient charts for those in the control group	—

Measure

Time frame

1. Decrease in Numerical Rating Scale (NRS) pain scores for different fracture types is measured at 30, 60 and 120 minutes after administration of the FICB for the FICB group and retrospectively from patient charts for those in the control group 2. Need for additional opioid analgesics is measured by emergency department and anesthesiology staff members, as well as members of the research team at 30, 60 and 120 minutes for the FICB group and retrospectively from patient charts for those in the control group 3. . Occurrence of side effects is measured by emergency department and anesthesiology staff members, as well as members of the research team at 30, 60 and 120 minutes for the FICB group and retrospectively from patient charts for those in the control group

—

Countries

Netherlands

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Mar 4, 2026